Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

ALLO

Allogene Therapeutics, Inc.

CIK 0001737287 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$2.09
↓ 0.01 (-0.48%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options; Risks: Fundamentals

Key stats

Market Cap
$721.37M
P/E Ratio
-4.36
EPS
-0.87
Dividend Yield
Not covered
52W Position
31%
Beta
2.17

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
1.65
P/S
Not covered
EV/Revenue
Not covered
ROE
-37.9%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 31%
$1.04$4.46

Latest Financials

2025-12-31 FY
Revenue
$0.00
Net Income
-$190.89M
Total Assets
$415.90M
Free Cash Flow
-$149.63M

Recent news